2008
DOI: 10.1002/ccd.21803
|View full text |Cite
|
Sign up to set email alerts
|

Assessment with optical coherence tomography of a new strategy for bifurcational lesion treatment: The Tryton Side‐Branch Stent

Abstract: The Tryton-Side Branch Stent (Tryton Medical, Inc., Newton, MA, USA) is a dedicated stent designed to provide complete carinal coverage of bifurcational lesions. After implantation of a 18 mm cobalt chromium Tryton stent from the left circumflex into the obtuse marginal branch, recrossing with an everolimus eluting Promus stent and final kissing balloon dilatation, optical coherence tomography (OCT) (LightLab Imaging Inc., Westford, MA, USA) was performed with a non-occlusive technique with motorized pullback … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
3
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
6
2
1

Relationship

2
7

Authors

Journals

citations
Cited by 16 publications
(5 citation statements)
references
References 39 publications
(92 reference statements)
0
3
0
Order By: Relevance
“…3,9 New imaging techniques with higher resolution than IVUS are available for atherosclerotic bifurcation disease assessment, such as optical coherence tomography, which could offer greater diagnostic precision of incomplete apposition and late stent thrombosis risk predictors. 10 However, there are limitations, such as the low availability at cardiac catheterisation units as well as the associated costs. Another possibility for bifurcation treatment is the use of fractional myocardial flow reserve in the lateral branch functional assessment and intervention requirement.…”
Section: Discussionmentioning
confidence: 99%
“…3,9 New imaging techniques with higher resolution than IVUS are available for atherosclerotic bifurcation disease assessment, such as optical coherence tomography, which could offer greater diagnostic precision of incomplete apposition and late stent thrombosis risk predictors. 10 However, there are limitations, such as the low availability at cardiac catheterisation units as well as the associated costs. Another possibility for bifurcation treatment is the use of fractional myocardial flow reserve in the lateral branch functional assessment and intervention requirement.…”
Section: Discussionmentioning
confidence: 99%
“…Most case reports visualise the complex anatomical structure of bifurcation dedicated stents in 3D OCT. Ferrante et al . [ 29 ] used OCT to assess the efficacy of the Tryton dedicated side branch stent in nine patients, and found that malapposed stent struts were more frequently seen at the level of the bifurcation than in the proximal and distal stent in the MV. In particular, the highest proportion of malapposed struts was seen towards the ostium of the side branch [ 29 , 30 ].…”
Section: Stenting In Bifurcation Lesion Using Oct Guidancementioning
confidence: 99%
“…[ 29 ] used OCT to assess the efficacy of the Tryton dedicated side branch stent in nine patients, and found that malapposed stent struts were more frequently seen at the level of the bifurcation than in the proximal and distal stent in the MV. In particular, the highest proportion of malapposed struts was seen towards the ostium of the side branch [ 29 , 30 ]. The following stents are used with provisional SB stenting approach.…”
Section: Stenting In Bifurcation Lesion Using Oct Guidancementioning
confidence: 99%
“…OCT has also been used to evaluate the effectiveness of new devices dedicated to bifurcation lesions. The efficacy of the Tryton dedicated side branch stent (Tryton Medical) was tested in small populations[17,18] then more widely in the Prospective, Single Blind, Randomized Controlled Study to Evaluate the Safety and Effectiveness of the Tryton Side Branch Stent Used With DES in the Treatment of De Novo Bifurcation Lesions in the MB and SB in Native Coronaries (TRYTON) trial,[19] which failed to demonstrate superiority of this new stent above conventional provisional stenting. Similarly, OCT was used to evaluate the STENTYS stent (STENTYS SA), a provisional, self-expanding nitinol drug-eluting or bare-metal stent reported to have a good success rate along with a low rate of major adverse cardiac events.…”
Section: Optical Coherence Tomography-guided Decision Makingmentioning
confidence: 99%